The Wall Street Journal is reporting that Bausch and Lomb plans to spin off its eye care business from its pharmaceutical business.
The Journal says the eye care unit is nearly half the company’s revenue.
The Wall Street Journal is reporting that Bausch and Lomb plans to spin off its eye care business from its pharmaceutical business.
The Journal says the eye care unit is nearly half the company’s revenue.